Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinand Sudbrock

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2010
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paragangliomaFerdinand Sudbrock, Matthias Schmidt, Thorsten Simon, et al.
EJNMMI Research|June 10, 2015
Characterization of SnO2-based (68)Ge/ (68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancyFerdinand Sudbrock, Thomas Fischer, Beate Zimmermanns, et al.
International Journal of Molecular Sciences|January 28, 2026
Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout ScenariosKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2011
Exhalation of ¹³¹I after radioiodine therapy: measurements in exhaled airKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
Nuclear Medicine Communications|November 13, 2009
Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?Carsten Kobe, Wolfgang Eschner, Markus Wild, et al.
Clinical Endocrinology|August 23, 2011
Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapyDeniz Kahraman, Christian Keller, Christina Schneider, et al.
International Journal of Molecular Sciences|July 12, 2025
Overcoming Multidrug Resistance Using DNA-Localized Auger Emitters: A Comparative Analysis of Radiotoxicity in Breast Cancer CellsKlaus Schomäcker, Beate Zimmermanns, Thomas Fischer, et al.
International Journal of Molecular Sciences|October 16, 2024
Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID MiceThomas Fischer, Christopher Dietrich, Felix Dietlein, et al.
Biomedicines|April 29, 2025
Radioiodine Exhalation Following Oral I-131 Administration in a Mouse ModelKlaus Schomäcker, Thomas Fischer, Ferdinand Sudbrock, et al.
NPJ Digital Medicine|January 8, 2026
Psychometric properties and detectability of GPT-4o-generated multiple-choice questions compared with human-authored items across imaging specialtiesPhilipp Linde, Florian Fichter, Markus Dietlein, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2010
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paragangliomaFerdinand Sudbrock, Matthias Schmidt, Thorsten Simon, et al.
EJNMMI Research|June 10, 2015
Characterization of SnO2-based (68)Ge/ (68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancyFerdinand Sudbrock, Thomas Fischer, Beate Zimmermanns, et al.
International Journal of Molecular Sciences|January 28, 2026
Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout ScenariosKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2011
Exhalation of ¹³¹I after radioiodine therapy: measurements in exhaled airKlaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer, et al.
Nuclear Medicine Communications|November 13, 2009
Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?Carsten Kobe, Wolfgang Eschner, Markus Wild, et al.
Clinical Endocrinology|August 23, 2011
Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapyDeniz Kahraman, Christian Keller, Christina Schneider, et al.
International Journal of Molecular Sciences|July 12, 2025
Overcoming Multidrug Resistance Using DNA-Localized Auger Emitters: A Comparative Analysis of Radiotoxicity in Breast Cancer CellsKlaus Schomäcker, Beate Zimmermanns, Thomas Fischer, et al.
International Journal of Molecular Sciences|October 16, 2024
Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID MiceThomas Fischer, Christopher Dietrich, Felix Dietlein, et al.
Biomedicines|April 29, 2025
Radioiodine Exhalation Following Oral I-131 Administration in a Mouse ModelKlaus Schomäcker, Thomas Fischer, Ferdinand Sudbrock, et al.
NPJ Digital Medicine|January 8, 2026
Psychometric properties and detectability of GPT-4o-generated multiple-choice questions compared with human-authored items across imaging specialtiesPhilipp Linde, Florian Fichter, Markus Dietlein, et al.
Pageof 2